These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33768016)

  • 1. Super Bioavailable Itraconazole and Its Place and Relevance in Recalcitrant Dermatophytosis: Revisiting Skin Levels of Itraconazole and Minimum Inhibitory Concentration Data.
    Sardana K; Mathachan SR
    Indian Dermatol Online J; 2021; 12(1):1-5. PubMed ID: 33768016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique.
    Saraswat A; Dogra S; Shenoy M; Verma S; K S; Ghate S; Ganjoo A; Aurangabadkar S; Tiwari A; Poojary S; Inamdar A; Majid I; Girdhar M; Shah B; Varma S; Ramamoorthy R; Dhoot D; Barkate H
    Dermatology; 2024; 240(4):671-683. PubMed ID: 38697027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India.
    Shenoy M; Dhoot D; Mahajan H; Barkate H
    Clin Cosmet Investig Dermatol; 2021; 14():1367-1376. PubMed ID: 34611418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.
    Patel NH; Sardana K; Shenoy MM; Rengasamy M; Khurana A; Ghate S; Venkata CK; Marfatiya Y; Bhunia D; Jayaraman J; Das A; Jain AK
    Indian Dermatol Online J; 2024; 15(1):1-7. PubMed ID: 38283009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis.
    Khattab F; Elkholy BM; Taha M; Abd-Elbaset A; Fawzy M
    Mycoses; 2022 Dec; 65(12):1194-1201. PubMed ID: 35943822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).
    Rengasamy M; Shenoy MM; Dogra S; Asokan N; Khurana A; Poojary S; Jayaraman J; Valia AR; Sardana K; Kolalapudi S; Marfatia Y; Rao PN; Bhat RM; Kura M; Pandhi D; Barua S; Kaushal V
    Indian Dermatol Online J; 2020; 11(4):502-519. PubMed ID: 32832435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis.
    Dhoot D; Jain GK; Manjhi M; Kesharwani P; Mahadkar N; Barkate H
    Drugs Context; 2023; 12():. PubMed ID: 36660014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameters that determine dissolution and efficacy of itraconazole and its relevance to recalcitrant dermatophytoses.
    Sardana K; Khurana A; Gupta A
    Expert Rev Clin Pharmacol; 2019 May; 12(5):443-452. PubMed ID: 30952196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India).
    Rajagopalan M; Inamadar A; Mittal A; Miskeen AK; Srinivas CR; Sardana K; Godse K; Patel K; Rengasamy M; Rudramurthy S; Dogra S
    BMC Dermatol; 2018 Jul; 18(1):6. PubMed ID: 30041646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial.
    Shenoy MM; De A; Shah B; Das A; Saraswat A; Lahiri K; Yadav S; Sarda A; Chakraborty D; J D; Kamat S; Doshi Y; Gonsalves N; Choudhary A; Dhoot D; Mahadkar N; Bhushan S; Gadkari R; Barkate H
    Drug Des Devel Ther; 2023; 17():2899-2908. PubMed ID: 37766823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis.
    Sharma P; Bhalla M; Thami GP; Chander J
    J Dermatolog Treat; 2020 Nov; 31(7):749-753. PubMed ID: 31030594
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermatophytes in Singapore.
    Goh CL; Tay YK; Ali KB; Koh MT; Seow CS
    Int J Dermatol; 1994 Oct; 33(10):733-7. PubMed ID: 8002147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: Genomic insights and resistance profile.
    Singh A; Masih A; Monroy-Nieto J; Singh PK; Bowers J; Travis J; Khurana A; Engelthaler DM; Meis JF; Chowdhary A
    Fungal Genet Biol; 2019 Dec; 133():103266. PubMed ID: 31491507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Efficacy and Safety of Super-Bioavailable Itraconazole-130 mg Once Daily in Obese and Non-Obese Patients of Glabrous Tinea.
    Shenoy M; De A; Shah B; Das A; Saraswat A; Lahiri K; Dhoot D
    Indian Dermatol Online J; 2023; 14(6):839-843. PubMed ID: 38099030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of hemolytic activity and in vitro antifungal susceptibility of Trichophyton rubrum clinical strains].
    Solgun G; Fındık D; Türk Dağı H; Arslan U
    Mikrobiyol Bul; 2011 Jan; 45(1):159-67. PubMed ID: 21341170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of
    Khurana A; Masih A; Chowdhary A; Sardana K; Borker S; Gupta A; Gautam RK; Sharma PK; Jain D
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea.
    Shah B; Mistry D; Jairam D; Kansara K; Pandya R; Vasani P; Dhoot D; Mahadkar N; Bhushan S; Barkate H
    Infect Drug Resist; 2023; 16():2409-2416. PubMed ID: 37125212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and/or tinea cruris.
    Parent D; Decroix J; Heenen M
    Dermatology; 1994; 189(4):378-81. PubMed ID: 7873824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive tinea capitis and corporis in a child caused by Trichophyton verrucosum.
    Jiang Y; Zhan P; Al-Hatmi AMS; Shi G; Wei Y; van den Ende AHGG; Meis JF; Lu H; de Hoog GS
    J Mycol Med; 2019 Apr; 29(1):62-66. PubMed ID: 30799183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dermatophytosis with new systemic antifungal agent, itraconazole.
    Noppakun N; Phuphaibool K
    J Med Assoc Thai; 1992 Feb; 75(2):99-103. PubMed ID: 1322949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.